Martina Bosnar

1.1k total citations
39 papers, 912 citations indexed

About

Martina Bosnar is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Molecular Biology. According to data from OpenAlex, Martina Bosnar has authored 39 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 12 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Martina Bosnar's work include Immune Response and Inflammation (10 papers), Asthma and respiratory diseases (8 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Martina Bosnar is often cited by papers focused on Immune Response and Inflammation (10 papers), Asthma and respiratory diseases (8 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Martina Bosnar collaborates with scholars based in Croatia, Bosnia and Herzegovina and United Kingdom. Martina Bosnar's co-authors include Vesna Eraković Haber, Michael J. Parnham, Vesna Munić Kos, Ines Glojnarić, Berislav Bošnjak, Snježana Čužić, Ognjen Čulić, Boška Hrvačić, Krunoslav Nujić and Mihailo Banjanac and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Martina Bosnar

38 papers receiving 860 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martina Bosnar Croatia 17 271 222 202 199 132 39 912
David J. Feola United States 18 321 1.2× 303 1.4× 270 1.3× 382 1.9× 104 0.8× 45 1.5k
Susan M. Phare United States 17 234 0.9× 246 1.1× 405 2.0× 377 1.9× 333 2.5× 22 1.3k
Karmen Brajša Croatia 16 159 0.6× 176 0.8× 60 0.3× 141 0.7× 81 0.6× 32 771
Shinobu Kobayashi Japan 15 130 0.5× 212 1.0× 80 0.4× 113 0.6× 68 0.5× 38 688
Alexander I. Kuzmenko United States 12 373 1.4× 201 0.9× 150 0.7× 99 0.5× 43 0.3× 15 762
Nurlan Dauletbaev Germany 20 356 1.3× 256 1.2× 109 0.5× 89 0.4× 183 1.4× 34 847
Timothy D. Bigby United States 24 291 1.1× 392 1.8× 325 1.6× 307 1.5× 485 3.7× 53 1.6k
Wei Dong China 22 264 1.0× 397 1.8× 192 1.0× 218 1.1× 55 0.4× 96 1.4k
Mari Numata United States 15 355 1.3× 202 0.9× 223 1.1× 245 1.2× 181 1.4× 35 930
Ines Glojnarić Croatia 15 245 0.9× 174 0.8× 137 0.7× 177 0.9× 114 0.9× 32 779

Countries citing papers authored by Martina Bosnar

Since Specialization
Citations

This map shows the geographic impact of Martina Bosnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martina Bosnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martina Bosnar more than expected).

Fields of papers citing papers by Martina Bosnar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martina Bosnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martina Bosnar. The network helps show where Martina Bosnar may publish in the future.

Co-authorship network of co-authors of Martina Bosnar

This figure shows the co-authorship network connecting the top 25 collaborators of Martina Bosnar. A scholar is included among the top collaborators of Martina Bosnar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martina Bosnar. Martina Bosnar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kovačević, Borislav, et al.. (2023). Cholinesterase Inhibitory and Anti-Inflammatory Activity of the Naphtho- and Thienobenzo-Triazole Photoproducts: Experimental and Computational Study. International Journal of Molecular Sciences. 24(19). 14676–14676. 9 indexed citations
3.
Kragol, Goran, Victoria A. Steadman, Martina Bosnar, et al.. (2022). Unprecedented Epimerization of an Azithromycin Analogue: Synthesis, Structure and Biological Activity of 2′-Dehydroxy-5″-Epi-Azithromycin. Molecules. 27(3). 1034–1034. 1 indexed citations
4.
Bosnar, Martina, et al.. (2022). New naphtho/thienobenzo-triazoles with interconnected anti-inflammatory and cholinesterase inhibitory activity. European Journal of Medicinal Chemistry. 241. 114616–114616. 20 indexed citations
7.
Banjanac, Mihailo, et al.. (2019). Precision-cut lung slices from bleomycin treated animals as a model for testing potential therapies for idiopathic pulmonary fibrosis. Pulmonary Pharmacology & Therapeutics. 55. 75–83. 27 indexed citations
8.
Rajković, Marija Grdić, et al.. (2019). Effects of extracellular Hsp70 and cigarette smoke on differentiated THP-1 cells and human monocyte-derived macrophages. Molecular Immunology. 111. 53–63. 14 indexed citations
10.
Bosnar, Martina, et al.. (2013). Immunomodulatory effects of azithromycin on the establishment of lipopolysaccharide tolerance in mice. International Immunopharmacology. 15(3). 498–504. 8 indexed citations
11.
Hrvačić, Boška, Martina Bosnar, Snježana Čužić, et al.. (2012). Cantharidin-induced inflammation in mouse ear model for translational research of novel anti-inflammatories. Translational research. 160(2). 137–145. 10 indexed citations
12.
Čorić, Ilija, et al.. (2012). Impact of stereochemistry on the biological activity of novel oleandomycin derivatives. Bioorganic & Medicinal Chemistry. 20(7). 2274–2281. 10 indexed citations
13.
Čužić, Snježana, Martina Bosnar, Željko Ferenčić, et al.. (2012). Claudin-3 and Clara Cell 10 kDa Protein as Early Signals of Cigarette Smoke–Induced Epithelial Injury along Alveolar Ducts. Toxicologic Pathology. 40(8). 1169–1187. 18 indexed citations
14.
Kos, Vesna Munić, Mihailo Banjanac, Sanja Koštrun, et al.. (2011). Intensity of macrolide anti-inflammatory activity in J774A.1 cells positively correlates with cellular accumulation and phospholipidosis. Pharmacological Research. 64(3). 298–307. 34 indexed citations
15.
Banjanac, Mihailo, Krunoslav Nujić, Martina Bosnar, et al.. (2011). Azithromycin distinctively modulates classical activation of human monocytes in vitro. British Journal of Pharmacology. 165(5). 1348–1360. 88 indexed citations
16.
Bosnar, Martina, Snježana Čužić, Berislav Bošnjak, et al.. (2010). Azithromycin inhibits macrophage interleukin-1β production through inhibition of activator protein-1 in lipopolysaccharide-induced murine pulmonary neutrophilia. International Immunopharmacology. 11(4). 424–434. 49 indexed citations
17.
Hrvačić, Boška, Berislav Bošnjak, Martina Bosnar, et al.. (2009). Clarithromycin suppresses airway hyperresponsiveness and inflammation in mouse models of asthma. European Journal of Pharmacology. 616(1-3). 236–243. 20 indexed citations
18.
Bosnar, Martina, Berislav Bošnjak, Snježana Čužić, et al.. (2009). Azithromycin and Clarithromycin Inhibit Lipopolysaccharide-Induced Murine Pulmonary Neutrophilia Mainly through Effects on Macrophage-Derived Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-1β. Journal of Pharmacology and Experimental Therapeutics. 331(1). 104–113. 72 indexed citations
19.
Bošnjak, Berislav, Boška Hrvačić, Martina Bosnar, et al.. (2006). Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysaccharide administration in mice. European Journal of Pharmacology. 539(1-2). 131–138. 77 indexed citations
20.
Parnham, Michael J., Ognjen Čulić, Vesna Eraković Haber, et al.. (2005). Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment. European Journal of Pharmacology. 517(1-2). 132–143. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026